- Well-established agent for more than 5 decades
- Provides rapid and predictable therapeutic plasma concentrations
- Indicated also in term newborns
Paracetamol Kabi
Details
- Features
- Characteristics
- Indication
- Packaging
- Dosage
- Product Info
Composition:
Each vial contains either 50 ml or 100 ml solution for infusion equivalent to 500 mg or 1,000 mg paracetamol.
Each vial contains either 50 ml or 100 ml solution for infusion equivalent to 500 mg or 1,000 mg paracetamol.
Therapeutic Indications:
Paracetamol Kabi is indicated for short-term treatment of moderate pain, especially following surgery, or short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.
Paracetamol Kabi is indicated for short-term treatment of moderate pain, especially following surgery, or short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.
Glass bottle 50ml & 100ml
| Body weight or age | Single dose | Maximum daily dose (taking all medicinal products containing paracetamol into account) |
| Pre-term newborn infants | No safety and efficacy data are available for pre-term newborn infants. | No safety and efficacy data are available for pre-term newborn infants. |
| Term newborn infants, infants, toddlers and children weighing up to 10 kg (up to approximately 1 year old) | 7.5 mg/kg paracetamol per administration, i.e. 0.75 ml solution per kg | • Up to four times a day • The minimum interval between each administration must be 4 hours • The maximum daily dose must not exceed 30 mg/kg |
| Children weighing more than 10 kg (approximately 1 year old) and up to 33 kg | 15 mg/kg paracetamol per administration, i.e. 1.5 ml solution per kg | Up to four times a day • The minimum interval between each administration must be 4 hours • The maximum daily dose must not exceed 60 mg/kg (i.e. maximum daily dose 2 g) |
| Children weighing more than 33 kg (approximately 11 years old), adolescents and adults weighing up to 50 kg | 15 mg/kg paracetamol per administration, i.e. 1.5 ml solution per kg | Up to four times a day • The minimum interval between each administration must be 4 hours • The maximum daily dose must not exceed 60 mg/kg (i.e. maximum daily dose 3 g) |
| Adolescents and adults weighing more than 50 kg | 1 g paracetamol per administration, i.e. one 100 ml vial | Up to four times a day • The minimum interval between each administration must be 4 hours • The maximum daily dose must not exceed 4 g |
Severe renal impairment:
It is recommended, when giving paracetamol to patients with severe renal impairment (creatinine clearance 30 ml/min), to increase the minimum interval between each administration to 6 hours.
Adults with hepatocellular insufficiency, chronic alcoholism, chronic malnutrition (low reserves of hepatic glutathione), dehydration:
The maximum daily dose must not exceed 3 g.
Method of administration:
For single use only. Any unused solution should be discarded.
Paracetamol Kabi solution for infusion can be diluted in sodium chloride 9 mg/ml (0.9 %) solution or 50 mg/ml glucose (5 %) solution up to one tenth. Before administration, the product should be visually inspected for any particulate matter and discolouration. The paracetamol solution is administered as a 15-minute intravenous infusion.
It is recommended, when giving paracetamol to patients with severe renal impairment (creatinine clearance 30 ml/min), to increase the minimum interval between each administration to 6 hours.
Adults with hepatocellular insufficiency, chronic alcoholism, chronic malnutrition (low reserves of hepatic glutathione), dehydration:
The maximum daily dose must not exceed 3 g.
Method of administration:
For single use only. Any unused solution should be discarded.
Paracetamol Kabi solution for infusion can be diluted in sodium chloride 9 mg/ml (0.9 %) solution or 50 mg/ml glucose (5 %) solution up to one tenth. Before administration, the product should be visually inspected for any particulate matter and discolouration. The paracetamol solution is administered as a 15-minute intravenous infusion.